Access cutting-edge crohn's disease treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access crohn's disease specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related crohn's disease treatment provided free
Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy and safety of TAK-279 versus placebo in participants with moderately to severely active Crohn's disease (CD). The main aim of this study is to learn if the 3 different doses of TAK-279 reduce bowel inflammation and ulcers in the bowel compared to the placebo after 12 weeks of treatment. Another aim is to compare any medical problems that
Sponsor: Takeda
Check if you qualify for this crohn's disease clinical trial in Atlanta, GA
If you're searching for crohn's disease treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced crohn's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.